Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
BS

BSX

Market Closed

Boston Scientific Corporation

NYSEHealthcareMedical - Devices
US
59.00K employees
CEO: Michael F. Mahoney
Founded: 1992
$44.34
+$0.00(+NaN%)
Market Cap
64.27B
Beta
0.58
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Boston Scientific’s current price at $45.13 is significantly below the PERT-weighted fair value of $75.00, indicating substantial implied upside of 66.2%. Monte Carlo analysis shows a wide value range with high volatility (104.14% coefficient of variation) and a downside risk of 20.6%, highlighting notable investment risk alongside growth potential. Overall financial health is good but growth scores are relatively low, suggesting moderate future expansion capacity.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore BSX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

BSX in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Medical - Devices

Browse industry stocks →